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Abstract  
Purpose: Recalibration and determining discriminative power, internationally, of the existing delirium 
prediction model (PRE-DELIRIC) for intensive care patients. 
Methods: A prospective multicenter cohort study was performed in eight intensive care units (ICUs) in six 
countries. The 10 predictors (age, APACHE-II, urgent and admission category, infection, coma, sedation, 
morphine use, urea level, metabolic acidosis) were collected within 24 hours after ICU admission. The confusion 
assessment method for the Intensive Care Unit (CAM-ICU) was used to identify ICU delirium. CAM-ICU 
screening compliance and inter-rater reliability measurements were used to secure the quality of the data. 
Results: 2,852 adult ICU patients were screened of which 1,824 (64%) were eligible for the study. Main reasons 
for exclusion were length of stay <1day (19.1%) and sustained coma (4.1%). CAM-ICU compliance was mean 
(SD) 82±16% and inter-rater reliability 0.87±0.17. The median delirium incidence was 22.5% (IQR 12.8%–
36.6%). Although the incidence of all ten predictors differed significantly between centers, the area under the 
receiver operating characteristic (AUROC) curve of the 8 participating centers remained good: 0.77 (95%CI: 
0.74-0.79). The linear predictor and intercept of the prediction rule were adjusted and resulted in improved re-
calibration of the PRE-DELIRIC model. 
Conclusions: In this multinational study we recalibrated the PRE-DELIRIC-model. Despite differences in the 
incidence of predictors between the centers in the different countries the performance of the PRE-DELIRIC-
model remained good. Following validation of the PRE-DELIRIC model it may facilitate implementation of 
strategies to prevent delirium and aid improvements in delirium management of ICU patients.   
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Introduction 
Delirium, the acute onset of confusion and consciousness disturbances with a fluctuating course [1], occurs 
frequently in critically ill patients [2-4]. Delirium is associated with a prolonged stay in the intensive care unit 
(ICU) and hospital, increased morbidity and mortality rate, higher costs [2, 3, 5] and adverse long-term outcome 
[6, 7]. There are several delirium assessment tools for ICU patients such as the Confusion Assessment Method 
for the Intensive Care Unit (CAM-ICU). Although recent studies [8, 9] showed a lower accuracy of the CAM-
ICU than in the original studies [10, 11], this screening tool has the highest sensitivity and specificity [12, 13]. 
Structured delirium screenings results in better recognition of delirious patients [14] that may facilitate early 
treatment [15, 16]. Besides adequate delirium treatment, prevention of delirium is crucial. While some 
preliminary studies have reported effective preventive interventions in both non-critically ill [17, 18] and ICU 
patients [19], applying these interventions in all ICU patients is time consuming, inefficient and exposes a 
substantial number of patients to unnecessary risks to possible side-effects of drugs used for delirium prevention. 
A readily available prediction model to identify high-risk patients would facilitate the use of preventive 
interventions. Recently, the PRE-DELIRIC prediction model was developed and validated for ICU patients [20] 
based on identified risk factors for delirium in ICU patients [21]. The development of the prediction model 
including the relevance of different delirium-associated risk factors in daily ICU practice, such as use of 
sedatives, morphine and presence of an infection are discussed more extensively in the original article [21]. The 
discriminative power of the PRE-DELIRIC model was high in predicting delirium with an onset at median day 
two after ICU admission [20]. Using the PRE-DELIRIC model is effective in predicting delirium and can be 
used to guide preventive therapy in critically ill patients [22], to stratify patients in testing the effectiveness of 
any considered intervention and to better inform caregivers and families.  
The PRE-DELIRIC model consists of ten predictors that are readily available within 24 hours following ICU 
admission and, with an area under the receiver operating characteristic curve (AUROC) of 0.85 [20] has a good 
performance. Since the PRE-DELIRIC model was developed and validated in the Netherlands, it is unknown 
what the multinational performance of this model is. In view of relevant differences in case mix and ICU 
treatment between countries, a good multinational performance of the PRE-DELIRIC model is warranted prior 
to worldwide implementation. 
In the present multinational study we recalibrated the model and determined the discriminative power of the 
PRE-DELIRIC model. 
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Methods 
Study design 
Prospective observational multicenter study carried out in eight general intensive care units for adult patients in 
six countries (Australia, Belgium, Germany, Spain, Sweden, United Kingdom). The regional Medical Ethical 
Committee of Arnhem-Nijmegen, The Netherlands (study number 2010/365) approved the study and waived the 
need for informed consent, since CAM-ICU determinations were part of clinical practice in all centers, no 
additional interventions were carried out, so data collection was not burdensome to patients, and data were 
captured and analyzed anonymously. All participating centers obtained ethics approval from the Ethical 
Committee of their own institution for data collection. 
 
Study population  
Each participating center included all eligible ICU patients during a period of three months. The first center 
started with inclusion in October 2011 and the last center started in June 2012. Patients were excluded if they 
were: delirious within 24 hours after ICU admission; sustained comatose during complete ICU stay; admitted to 
the ICU for less than one day; suffering from serious auditory or visual disorders; unable to understand the 
language of the included center; severely mentally disabled; suffering from a serious receptive aphasia; or if the 
compliance rate of the delirium screening was <80% during a patients’ stay in the ICU. To exclude a potential 
source of bias, the assessors of the CAM-ICU were not aware of collecting the data of the predictors neither the 
PRE-DELIRIC score and did not receive the calculated risk to develop delirium for their patient. 
 
Delirium screening 
In order to detect delirium, all ICU patients were assessed by well-trained ICU nurses with the validated delirium 
assessment tool the CAM-ICU [10, 11] at least twice daily. Identical to the original study [20], delirium was 
defined as at least one positive CAM-ICU screening during a patients’ complete intensive care stay. CAM-ICU 
was part of clinical practice in all participating hospitals.  
 
Data collection  
Data relating to delirium screening was collected during patients’ complete ICU stay. The ten predictors of the 
PRE-DELIRIC model as originally defined [20] were collected within the first 24 hours after ICU admission: 
age, APACHE-II score, coma, urgent admission (unplanned ICU admission), admission category (surgical, 
medical, trauma, neurology/neurosurgical), infection, coma, use of sedatives, morphine use (three dosages 
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groups), urea level, and metabolic acidosis [20]. All predictors can objectively be measured and are well defined 
(Appendix A).  
A secured web based electronic clinical report form (E-CRF) was filled out for each screened patient using a 
unique login and password for each participating center. Consecutive patients received a unique anonymous 
number. For privacy reasons, only the participating centers were able to identify their patients’, based on the E-
CRF-numbers. 
 
Data management and quality checks  
To ensure the quality of the data, the compliance with the CAM-ICU was calculated monthly. Compliance was 
calculated as the percentage of assessments performed per day in relation to the total number of assessments that 
should have been performed. To determine the quality of the performed delirium screenings during the study 
period, monthly inter-rater reliability measurements were performed for all patients admitted to the ICU on a 
given day each month. For this, the CAM-ICU screenings assessed by the intensive care nurse were compared 
with the scores assessed by a dedicated delirium expert nurse or investigator in each center.  
We determined a priori that a CAM-ICU screening compliance >80% and an inter-rater reliability of >0.80 
Cohen’s kappa indicated reliable data. The performance of the PRE-DELIRIC model was calculated after 
excluding data of the center(-s) who did not achieve this compliance or kappa from the analysis. Exclusion and 
re-analysis was performed per centre. If exclusion of this center did not affect the performance of the PRE-
DELIRIC model significantly results centers were included in the final analyses.  
 
Statistical analysis  
Missing predictor data were imputed in a similar way as in the original study [20]. We assumed that if a blood 
value was not determined, most likely the missing variable had a normal value, so the mean normal value of the 
study population was imputed. For other missing variables we assumed that they had a normal or negative value 
(i.e. no infection, no metabolic acidosis) or a mean value (e.g. APACHE-II score) of the study population and 
imputed the mean value of the variable derived from the delirium or non-delirium group, depending on the 
results of the delirium assessment. The percentage of missing data ranged between <1.0% and 9.8%. We 
recorded incomplete data for the presence of infection (9.8%), highest urea level (1.8%), APACHE-II score 
(1.5%) and metabolic acidosis (<1.0%). Data of all other variables were complete. 
To determine the performance of the PRE-DELIRIC model for each participating center the original linear 
predictors were used to calculate the probability of developing delirium for each patient. The estimated 
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prognostic ability of the model was determined using the area under the receiver operating characteristic curve 
(AUROC) of the calculated total predicted probability per patient and his/her delirium outcome.  
In order to optimize the calibration of the model we used the linear predictors and the intercept in a logistic 
regression model. For this a generally accepted [23, 24] standard statistical stepwise approach was followed in 
order to achieve a calibration slope of 1 and an intercept of 0, as a measure of perfect calibration. To test this we 
used the weights of the linear predictors in a logistic regression analysis resulting in an intercept and a 
calibration slope. The first approach was to estimate a new intercept and use a fixed calibration slope of 1. Next, 
we estimated the intercept as well as the calibration slope. Then we estimated the intercept for each center 
separately with again a fixed calibration slope, followed by estimation of intercept as well as calibration slope 
per center. With the last approach to optimize the calibration we then applied a general linear mixed model fit by 
Laplace approximation, using the mean estimated intercept and mean estimated calibration slope. In order to 
determine if recalibration could be biased by data of the largest group of patients from one center, we also 
calculated an intercept and linear predictor using weighted data. In order to test the calibration we used the 
Hosmer-Lemeshow goodness-of-fit statistics before and after recalibration [25], and to judge the calibration and 
recalibration visually we used calibration belts as described by Finazzi et al. [26].  
Statistical analyses were performed using Statistical Package for Social Sciences (SPSS®) 20.01, R statistics 
version 2.10.1 [27] using the rms package [28]  
 
Sample size 
The PRE-DELIRIC model consists of ten predictors. We would needed at least 10-15 patients with delirium and 
10-15 patients without delirium per predictor for the validation and re-calibration, so in total at least 300 patients. 
This formula was based on the recommendation for the development of a new prediction model [23]. With an 
anticipated delirium incidence of 15-30%, an attrition of 25%, we aimed to enroll at least 1350 patients.  
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Results  
A total of 2,852 ICU patients were screened, with 1,824 (64%) patients included in the analysis. The most 
frequent reason for exclusion was a length of stay on the ICU <1 day (19.1%), followed by sustained coma 
(4.1%) and development of delirium within 24 hrs (3.5%) (Figure 1). The mean±SD age of patients was 
60±17years, the mean APACHE-II score was 19±9, and 57% of the included patients were male. Most patients, 
over 50%, had a predicted delirium chance between 10-20%, Appendix B. 
The median delirium incidence was 22.5% (IQR 12.8%–36.6%). The median time till first positive CAM-ICU 
occurred was 3 [1-6] days. Of note, apart from the considerable variation in delirium incidence there were 
important differences between countries concerning the incidence of delirium predictors (Table 1).  
 
CAM-ICU compliance and inter rater reliability  
The overall CAM-ICU compliance was 82±16% (minimum 52% and maximum 100%) and the mean inter-rater 
reliability measurements were 0.87±0.17 Cohen’s kappa (minimum 0.57 and maximum 1.00), Appendix C. In 
total 461 inter rater measurements were performed. There were 10 false negative scores and 11 false positive 
scores resulting in a sensitivity of 0.93 (95%CI: 0.86-0.95) and a specificity of 0.97 (95%CI: 0.95-0.98).  
 
Discrimination and recalibration of the PRE-DELIRIC 
To determine the discriminative power of the PRE-DELIRIC model the AUROC was calculated per center and 
overall. The mean AUROC of the eight participating centers was 0.77 (95%CI: 0.74-0.79), Appendix D. The 
AUROC of the model in the early onset delirium group was 0.82 (95%CI 0.79-0.84) and for the late onset 
delirium group 0.68 (95%CI 0.66-0.71). The sensitivity of the PRE-DELIRIC model in this study was 0.70 and 
the specificity of 0.73 with a positive and negative Likelihood ratio of 2.43 and 0.39, respectively. After 
discarding all data of the centers with an overall CAM-ICU compliance below 80% (Appendix B) the AUROC 
remained similar: 0.79 (95% 0.76-0.82). The mean inter-rater reliability of all centers was >0.80.  
To recalibrate the prediction model, four different approaches were used and calculated, as described in the 
statistical analysis section. None of the first three approaches resulted in a good calibration defined as a 
calibration slope of nearly 1 and an intercept of nearly 0 (data not shown). Using the general linear mixed model 
method resulted in an adjustment of the original intercept (-6.31*0.4724 -1.0545). To optimize the calibration 
slope each linear predictor was then multiplied with 0.4724 resulting in new predicted probabilities (Appendix 
D) per center. Table 2 reflects the old and new linear predictors and the intercept. This recalibration resulted in 
improvement of the calibration curve (Figure 2a and 2b), with a calibration slope of 1.09 and an intercept of 
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0.08. Following adjustment of the calibration slope the AUROC remained similar: 0.76 (95%CI 0.74-0.79). The 
Hosmer-Lemeshow test improved, Chi-square 797.95 (p<0.0001) before recalibration to Chi-square 15.85 (p 
0.045) after recalibration, indicating a better overall calibration. 
Sequentially we calculated a new intercept and linear predictor using a weighted data to determine if the center 
with the largest sample size biased our results. This resulted in a poorer calibration (data not shown). 
Importantly, in this center no inter-rater reliability was measured and had the highest APACHE-II score with a 
relatively low delirium incidence. 
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Discussion  
We previously showed that the prediction of delirium by caregivers is inaccurate and that the PRE-DELIRIC 
model is of additional value [20]. However, as the model was developed and validated in the Netherlands, the 
predictive value of the model in other countries was unknown. In this multinational study we determined the 
discriminative power of the PRE-DELIRIC model for ICU patients was similar to the previous study and the 
calibration of the model was optimized. 
In our study we found important differences between countries regarding the incidence of the ten 
predictors as well as the delirium incidence, which potentially could be explained by differences in case mix, 
severity of illness and differences in ICU admission policies, such as sedation protocols, and other ICU 
treatments. Although remarkably, and in line with other studies [29, 30], in our study the most sedated patients, 
and patients in coma within the first 24hrs after ICU admission, have the highest rate of delirium (table 1). 
Nevertheless, since no information was collected that may explain the reason of the observed differences in data 
entered into the model, we cannot further speculate about this and other differences. The differences in incidence 
of the predictors, and the already existing slightly overestimation of the model in the Dutch population [20], 
necessitated halving of the coefficient values of the predictors in order to optimize the calibration of the model in 
the multinational population. Despite these differences between the countries, the discriminative power of the 
PRE-DELIRIC model was not affected, indicating that the most important predictors for the development of 
delirium on the ICU are included in the model.  
Furthermore, in this multinational study we only collect data of predictors which are in the PRE-
DELIRIC model. Although we feel that others risk factors such as excessive alcohol consumption is clearly a 
very important risk factor to develop delirium, this risk factor was not in the original PRE-DELIRIC model [20]. 
Regarding the purpose of this study it is not appropriate to include other/additional risk factors. This would result 
in a completely new development of a delirium prediction model. Without the risk factor alcohol withdrawal the 
predictive value of the original model was high, despite we did not measured the prevalence of alcohol 
withdrawal in this multinational study, the performance of the model remained high. Alcohol withdrawal (acute 
withdrawal, delirium tremens, and its clinical manifestation) should be clearly distinguished from delirium itself. 
However, it is important to recognize that alcohol consumption itself is a risk factor for “plain” delirium [31, 32]. 
We feel that for patients with a high alcohol consumption or withdrawal we do not need a prediction model, 
these patients have a high risk and delirium preventive measures are anyway indicated for this group. 
The increased morbidity and mortality associated with delirium in ICU patients warrant its prevention. 
There is some evidence that delirium prevention, i.e. by haloperidol is effective in non-cardiac surgery ICU 
11 
 
patients [19]. Importantly, the estimate of the efficacy of haloperidol in this study [19] is likely diluted since the 
preventive intervention was used in all patients, irrespective of their delirium risk. Theoretically, exclusion of 
ICU patients with a low risk of developing delirium may better reveal the beneficial effects of preventive 
measures. Indeed, with use of the PRE-DELIRIC model we previously showed that a low dose of haloperidol 
was associated with a reduced rate of delirium and mortality among ICU patients with a predicted risk of 
developing delirium >50%, and seems even more effective in the highest risk (predicted risk >90%) group [22]. 
However, this study was a pre-post design study that needs to be confirmed in a RCT, it illustrates the need for a 
delirium prediction model to facilitate the conduct of future prevention studies.  
Importantly, the PRE-DELIRIC model is a static prediction model producing a single risk prediction 
value 24 hours after ICU admission. However, delirium in ICU patients is a complex, dynamic and multi-
factorial syndrome. The current PRE-DELIRIC model may require on-going validation as new therapies and 
interventions emerge. For example, the use of new sedatives or analgesics may affect the development of 
delirium [33-35] and consequently could affect the performance of the model. Different risk factors may emerge 
in the future that may need to be investigated and included in the current PRE-DELIRIC model. In addition, 
since some patients develop delirium within 24 hours after ICU admission, an early delirium prediction model 
appears necessary in order to facilitate preventive measures in high risk patients immediately after ICU 
admission. 
Furthermore, the discriminative power of the model remained similar and the calibration was optimized. 
Regarding the calibration plot there is still some overestimation of the PRE-DELRIC model for patients with a 
calculated risk of 50% and higher. It appears plausible that for the high risk group the study was underpowered, 
resulting in the observed overestimation. However, in these patients with a high-risk to develop delirium it is 
recommendable anyway to take preventive interventions, so the small overestimation of the model would not 
affect clinical decision making.  
Our study has several limitations we wish to address. In our multinational study the discriminative 
power remained good. During the recalibration process it appeared that the most optimal way to recalibrate the 
model was to estimate a new intercept and linear predictors for each center separately. The best performance can 
be achieved when a prediction model is tailored to suit each individual ICU. This would result in the best 
discriminative power and calibration of such a model, but would impair comparisons between centers. Therefore, 
we feel it is desirable to have a prediction model that can be used in all hospitals and we chose to use the mean 
estimated new linear predictors and intercept of all hospitals. In this way the discriminative power remained 
high. Nevertheless, centers need to take into account that there can be some over- or underestimation in the 
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prediction of delirium when using the PRE-DELIRIC model in their ICU, especially in the highest risk group. 
Therefore caution is needed with the use of the model in patient populations with a high probability of delirium. 
In addition, since the PRE-DELIRIC model is now recalibrated using multinational data, a prospective 
multinational validation of the recalibration is warranted. 
Second, coma represented by RASS level -3 or less, is an important predictor in the PRE-DELIRIC model, but 
coma can be biased by the effect of sedation which is suggested to be a confounder for delirium [36]. In our 
study we did not collect data on the duration of coma or on the relation between sedation and the relation with 
the onset of delirium. However, when excluding the predictor ‘sedation or coma’ from the model, this did not 
influence the discriminative power (data not shown), indicating that this did not affect our results to an important 
extent. Third, for missing data we did not use a specific imputation technique [37], however, in our view, a 
clinically relevant method to handle missing values. We assumed, similar to the original PRE-DELIRIC study 
[20], that a missing variable had a normal value, as there were apparently no indications to measure this variable, 
and consequently imputed the normal value. Since the incidence of missing values was low, our results were not 
affected importantly using this imputation technique. Fourth, we assessed the presence of delirium using the 
CAM-ICU. The performance of this assessment tool in daily practice has been re-evaluated recently [8, 9], and 
also been discussed in sedated patients [38, 39] and may not be as accurate as in the original validation studies 
[10, 11], however, ongoing bedside education results in a better performance [40]. On the other hand, in the re-
evaluation studies the CAM-ICU was measured only once and compared with an expert screening, while in our 
multinational study the delirium diagnosis was based on all consecutive CAM-ICU screenings during a patients’ 
complete ICU stay, increasing its sensitivity. Finally, we set threshold values for good data quality concerning 
CAM-ICU compliance and even inter-rater reliability measurements. Although not all centers achieved these 
thresholds, we demonstrated that this did not affect our results significantly. These issues increase the 
generalizability of our results, because the lower compliance with CAM-ICU screening may simply reflect real-
life clinical practice.  
 
Conclusion 
The discriminative value of the PRE-DELIRIC model to predict delirium in ICU patients was confirmed and the 
predictive value of the model improved after recalibration in this multinational study. However, following 
recalibration, the model needs to be validated prospectively in order to support its use in clinical practice. 
Furthermore, caution is needed with the use of the model in patient populations with a high probability of 
delirium.  
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Table 1. Patient characteristics and predictors of included patients of the participating hospitals 
 Belgium 
Antwerp 
(n=566) 
Germany 
Berlin 
(n=223) 
Spain 
Madrid 
(n=128) 
Sweden 
Stockholm 
(n=77) 
Australia 
Brisbane 
(n=329) 
Australia 
Canberra 
(n=195) 
UK 
Prescot 
(n=235) 
UK 
Kent 
(n=71) 
Age, years (mean, SD) 61±15 62±16 60±17 61±17 55±18 63±16 62±17 62±17 
APACHE-II points (mean, SD) 26±8 17±8 8±5 14±7 16±6 18±6 17±7 15±7 
No coma  
Coma due to: 
- Medication induced 
- Miscellaneous 
- Combination 
499 (88%) 
 
58 (10%) 
0 
9 (2%) 
184 (83%) 
 
37 (17%) 
2 (1%) 
0 
114 (89%) 
 
14 (11%) 
0 
0 
47 (61%) 
 
23 (30%) 
1 (1%) 
6 (8%) 
239 (73%) 
 
31 (9%) 
5 (2%) 
54 (16%) 
146 (75%)  
 
34 (17%) 
4 (2%) 
11 (6%) 
138 (59%) 
 
70 (30%) 
4 (2%) 
23 (10%) 
38 (54%) 
 
28 (39%) 
5 (7%) 
0 
No morphine use 
- Morphine 0.01-7.1mg/day 
- Morphine 7.2-18.6mg/day 
- Morphine >18.6mg/day 
347 (79%) 
30 (7%) 
41 (9%) 
20 (5%) 
203 (91%) 
10 (5%) 
8 (4%) 
2 (1%) 
77 (61%) 
13 (10%) 
23 (18%) 
13 (10%) 
25 (42%) 
11 (18%) 
15 (25%) 
9 (15%) 
258 (82%) 
7 (2%) 
19 (6%) 
31 (10%) 
182 (94%) 
2 (1%) 
3 (2%) 
7 (4%) 
175 (75%) 
4 (2%) 
6 (3%) 
48 (21%) 
66 (93%) 
0 
0 
5 (7%) 
Sedated  194 (34%) 35 (16%) 21 (16%) 43 (56%) 271 (82%) 83 (43%) 94 (40%) 33 (47%) 
Urgent admission 330 (58%) 114 (51%) 45 (35%) 61 (79%) 159 (48%) 149 (76%) 228 (97%) 61 (86%) 
Diagnose group 
- Surgical 
- Medical 
- Trauma 
- Neurology/neurosurgical 
 
286 (51%) 
164 (29%) 
1 (0%) 
115 (20%) 
 
110 (49%) 
55 (25%) 
24 (11%) 
34 (15%) 
 
92 (72%) 
8 (6%) 
2 (2%) 
26 (20%) 
 
26 (34%) 
39 (51%) 
12 (16%) 
0 
 
196 (60%) 
77 (23%) 
42 (13%) 
14 (4%) 
 
63 (32%) 
112 (57%) 
12 (6%) 
8 (4%) 
 
65 (28%) 
161 (69%) 
4 (2%) 
5 (2%) 
 
31 (44%) 
38 (54%) 
2 (3%) 
0 
Infection or strong suspicion 92 (16%) 39 (18%) 19 (15%) 51 (66%) 99 (30%) 80 (41%) 97 (41%) 39 (55%) 
Metabolic acidosis 205 (36%) 18 (8%) 26 (20%) 29 (38%) 57 (17%) 91 (47%) 90 (38%) 9 (13%) 
Highest urea level in mmol/L 4.9±3.7 16.0±11.3 15.5±7.6 11.1±8.7 7.9±6.4 9.3±5.9 11.5±9.6 13.5±12.7 
Delirious, n (%) 86 (15%) 60 (27%) 23 (18%) 30 (39%) 42 (13%) 23 (12%) 73 (31%) 26 (37%) 
Data are expressed as mean with standard deviation, unless reported otherwise
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Figure 2a. Calibration belt before recalibration  
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Figure 2b. Calibration belt after recalibration  
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Appendix A. Supplement for web-only publication 
 
Collected delirium predictors within 24 hours after intensive care admission 
Variable Category Description 
Age (years) C Continuous variable 
APACHE-II score (per point) C Calculated 24 hours after ICU admission 
Coma  Cat 
No coma: RASS-4/-5 maximum 8 hours 
RASS-4/-5 for longer than 8 hours: 
1. With use of medication 
2. Other (i.e. intra cerebral bleeding, post-resuscitation) 
3. Combination (1+2) 
Admission category Cat  
1. Surgical 
2. Medical  
3. Trauma  
4. Neurology/neurosurgical 
Infection D Proven or strong suspicion of infection for which antibiotics were started 
Metabolic acidosis*  D pH <7.35 with bicarbonate <24mmol/L 
Morphine use Cat 
No morphine: no use of any morphine 
Cumulative use of any form of morphine: 
1. 0.01-7.1mg 
2. 7.2-18.6mg 
3. 18.7mg or more 
Sedative use D Any use of propofol, midazolam, lorazepam or combination 
Urgent admission D Unplanned intensive care admission  
Urea (mmol/L ) C Continuous variable, highest value in blood 
C= continuously    D=dichotomized  Cat.=categorical 
 
 
Appendix B. Supplement for web-only publication 
 
Predicted probabilities to develop delirium in decentiles groups 
 Number of patients (%) 
0 - 10% prediction 356 (19.5) 
10-20% prediction 923 (50.6) 
20-30% prediction 251 (13.8) 
30-40% prediction 105 (5.8) 
40-50% prediction 72 (3.9) 
50-60% prediction 47 (2.6) 
70-80% prediction 32 (1.8) 
80-90% prediction 11 (.6) 
90-100% prediction 0 
 
 
Appendix C. Supplement for web-only publication 
 
CAM-ICU compliance in %, and inter rater reliability measurements in Cohen’s kappa 
 CAM-ICU 
compliance 
Inter rater 
reliability# 
Belgium  78±7 not available 
Germany  84±22 0.87±0.04 
Spain 93±9 0.89±0.06 
Sweden 88±11 0.87±0.13 
Australia Brisbane 78±19 0.29±0.23 
Australia Canberra 100 not performed* 
UK_Prescot  61±1 0.79±0.09 
UK_Kent  87±6 0.87±0.13 
Overall 83±16 0.86±0.03 
Data are expressed as mean and standard deviation 
* In this center all CAM-ICU were assessed by two dedicated research nurses, making this not applicable 
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Appendix D. Supplement for web-only publication 
 
AUROC of different hospitals/countries using PRE-DELIRIC en predicted probabilities 
 Delirium  Median [IQR] 
predicted probability 
before recalibration 
Median [IQR] 
predicted probability 
after recalibration 
AUROC 95% CI 
Belgium (%) 86 (15.2) 0.12 [0.08-0.25] 0.13 [0.11-0.21] 0.79 0.74-0.84 
Germany (%) 60 (26.9) 0.09 [0.07-0.17] 0.11 [0.10-0.13] 0.85 0.80-0.91 
Spain (%) 23 (18.0) 0.08 [0.06-0.11] 0.10 [0.09-0.13] 0.88 0.81-0.94 
Sweden (%) 30 (39.0) 0.22 [0.09-0.41] 0.19 [0.12-0.32] 0.71 0.60-0.83 
Australia Brisbane (%) 42 (12.8) 0.13 [0.09-0.33] 0.14 [0.11-0.25] 0.81 0.75-0.88 
Australia Canberra (%) 23 (11.8) 0.16 [0.09-0.33] 0.16 [0.11-0.26] 0.80 0.72-0.89 
Australia overall 65 (12.4)   0.81 0.76-0.86 
UK_Prescot (%) 73 (30.8) 0.19 [0.09-0.36] 0.18 [0.12-0.27] 0.65 0.57-0.73 
UK_Kent (%) 26 (36.6) 0.20 [0.07-0.41] 0.18 [0.10-0.32] 0.76 0.65-0.88 
UK_overall 99 (32.4)   0.68 0.62-0.74 
PRE-DELIRIC overall 363 (19.9)   0.77 0.74-0.79 
Data are expressed as median with interquartile (25% and 75%) range, unless reported otherwise 
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